HK$ 35.84
Key Takeaways
Risk factor
Fair trading liquidity
Profitability factor
Very strong margins and returns
About
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, and metabolic diseases. Its principal products include Mailingda, a drug for the treatment of chronic...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of 3692.HK is 43 and suggests 20% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
